These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37325898)

  • 1. Temporal evolution of the heart failure phenotype in Barth syndrome and treatment with elamipretide.
    Sabbah HN; Taylor C; Vernon HJ
    Future Cardiol; 2023 Mar; 19(4):211-225. PubMed ID: 37325898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.
    Sabbah HN
    Heart Fail Rev; 2021 Mar; 26(2):237-253. PubMed ID: 33001359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
    Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X
    Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid.
    Sabbah HN
    Heart Fail Rev; 2022 Sep; 27(5):1911-1923. PubMed ID: 34623544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism.
    Reid Thompson W; Hornby B; Manuel R; Bradley E; Laux J; Carr J; Vernon HJ
    Genet Med; 2021 Mar; 23(3):471-478. PubMed ID: 33077895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome.
    Zhang J; Liu X; Nie J; Shi Y
    Autophagy; 2022 Sep; 18(9):2134-2149. PubMed ID: 34985382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy.
    Chatfield KC; Sparagna GC; Specht KS; Whitcomb LA; Omar AK; Miyamoto SD; Wolfe LM; Chicco AJ
    J Inherit Metab Dis; 2022 Jan; 45(1):111-124. PubMed ID: 34821394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Mitochondrial Ca
    Bertero E; Nickel A; Kohlhaas M; Hohl M; Sequeira V; Brune C; Schwemmlein J; Abeßer M; Schuh K; Kutschka I; Carlein C; Münker K; Atighetchi S; Müller A; Kazakov A; Kappl R; von der Malsburg K; van der Laan M; Schiuma AF; Böhm M; Laufs U; Hoth M; Rehling P; Kuhn M; Dudek J; von der Malsburg A; Prates Roma L; Maack C
    Circulation; 2021 Nov; 144(21):1694-1713. PubMed ID: 34648376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle.
    Ronvelia D; Greenwood J; Platt J; Hakim S; Zaragoza MV
    Mol Genet Metab; 2012 Nov; 107(3):428-32. PubMed ID: 23031367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barth syndrome in a female patient.
    Cosson L; Toutain A; Simard G; Kulik W; Matyas G; Guichet A; Blasco H; Maakaroun-Vermesse Z; Vaillant MC; Le Caignec C; Chantepie A; Labarthe F
    Mol Genet Metab; 2012 May; 106(1):115-20. PubMed ID: 22410210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER.
    Thompson WR; Manuel R; Abbruscato A; Carr J; Campbell J; Hornby B; Vaz FM; Vernon HJ
    Genet Med; 2024 Jul; 26(7):101138. PubMed ID: 38602181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Barth Syndrome Patient-Derived
    Snider PL; Sierra Potchanant EA; Sun Z; Edwards DM; Chan KK; Matias C; Awata J; Sheth A; Pride PM; Payne RM; Rubart M; Brault JJ; Chin MT; Nalepa G; Conway SJ
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.
    Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
    Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
    Ye C; Shen Z; Greenberg ML
    J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cardiolipin in Cardiovascular Health.
    Shen Z; Ye C; McCain K; Greenberg ML
    Biomed Res Int; 2015; 2015():891707. PubMed ID: 26301254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiolipin deficiency leads to the destabilization of mitochondrial magnesium channel MRS2 in Barth syndrome.
    Joshi A; Gohil VM
    Hum Mol Genet; 2023 Dec; 32(24):3353-3360. PubMed ID: 37721533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome.
    Petit PX; Ardilla-Osorio H; Penalvia L; Rainey NE
    Cells; 2020 Oct; 9(10):. PubMed ID: 33096711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data.
    Van den Eynde J; Chinni B; Vernon H; Thompson WR; Hornby B; Kutty S; Manlhiot C
    Orphanet J Rare Dis; 2023 Apr; 18(1):76. PubMed ID: 37041653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.